Litigation Details for BRACCO DIAGNOSTICS INC. v. MAIA PHARMACEUTICALS, INC. (D.N.J. 2017)
✉ Email this page to a colleague
BRACCO DIAGNOSTICS INC. v. MAIA PHARMACEUTICALS, INC. (D.N.J. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-12-14 |
| Court | District Court, D. New Jersey | Date Terminated | 2020-01-06 |
| Cause | 15:1126 Patent Infringement | Assigned To | Peter G. Sheridan |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 6,803,046 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BRACCO DIAGNOSTICS INC. v. MAIA PHARMACEUTICALS, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for BRACCO DIAGNOSTICS INC. v. MAIA PHARMACEUTICALS, INC. (D.N.J. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-12-14 | 1 | Exhibit US Patent 6,803,046 | DIAGNOSTICS INC.. (Attachments: # 1 Exhibit US Patent 6,803,046)(KAO, HUAI-HUNG) Modified on 12/15/2017 (eu…December 2017 7 January 2020 3:17-cv-13151 Patent None District Court, D. New Jersey | External link to document |
| 2019-10-03 | 85 | Memorandum | concerning United States Patent No. 6,803,046 (the “046 Patent”). The ‘046 Patent is listed to market and…eight amino acids bound together. (‘046 Patent at 1:9-16). The patent also claims five other ingredients:…It is a ‘bedrock principle’ of patent law that ‘the claims of a patent define the invention to which …invention. (‘046 Patent at 11:29-63 (emphasis added)). In addition, example 3 of the patent indicates that…parties dispute the meaning of three terms in the patent: (1) buffer; (2) surfactant/solubilizer; and (3 | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
